Mbd Co., Ltd.

Bosung Ku

Sang-Hyun Lee

Min Ji Lee

Gun Hwa Kim

Ji Hoon Lee

Sin Hyoung Hong

The present invention relates to a novel quinoline compound and a use thereof and to a novel quinoline compound exhibiting CYP4A inhibition activity and a use thereof for preventing, alleviating, treating a metabolic disease. The compound disclosed in the present invention has a remarkable effect of inhibiting CYP4A and exhibits the activities of promoting the absorption of glucose into hepatocytes, inhibiting fat accumulation in hepatocytes, suppressing endoplasmic reticulum-induced reactive oxygen species, and treating steatohepatitis, and thus can be very advantageously used for developing therapeutics for metabolic diseases such as diabetes mellitus and fatty liver.

Quinoline compound and use thereof

A pillar unit for a bio chip can include a plate-form substrate having a plurality of holder parts, which are spaced apart from each other, and each of the plurality of holder parts includes a holding space, to which a pillar is inserted and fixed, in which each of the plurality of holder parts further includes a pair transformation slits so that the corresponding holder part may be transformed and restored while the pillar is accommodated in the holding space; and a plurality of pillars corresponding to the plurality of holder parts, each of the plurality of pillars is accommodated in the holding space in one of the plurality of holder parts, one end of each of the plurality of pillars is combined with one holder part among the plurality of holder parts and is detachable, and the other end of each of the pillars includes a sample.

Growing community of inventors

Yongin-si, South Korea

Bosung Ku